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A B S T R A C T
New and aﬀordable point-of-care testing (POCT) solutions are hoped to guide antibiotic prescription and to help
limit antimicrobial resistance (AMR)—especially in low- and middle-income countries where resource con-
straints often prevent extensive diagnostic testing. Anthropological and sociological research has illuminated the
role and impact of rapid point-of-care malaria testing. This paper expands our knowledge about the social
implications of non-malarial POCT, using the case study of a C-reactive-protein point-of-care testing (CRP POCT)
clinical trial with febrile patients at primary-care-level health centres in Chiang Rai province, northern Thailand.
We investigate the social role of CRP POCT through its interactions with (a) the healthcare workers who use it,
(b) the patients whose routine care is aﬀected by the test, and (c) the existing patient-health system linkages that
might resonate or interfere with CRP POCT. We conduct a thematic analysis of data from 58 purposively sampled
pre- and post-intervention patients and healthcare workers in August 2016 and May 2017.
We ﬁnd widespread positive attitudes towards the test among patients and healthcare workers. Patients’
views are inﬂuenced by an understanding of CRP POCT as a comprehensive blood test that provides speciﬁc
diagnosis and that corresponds to notions of good care. Healthcare workers use the test to support their nego-
tiations with patients but also to legitimise ethical decisions in an increasingly restrictive antibiotic policy en-
vironment. We hypothesise that CRP POCT could entail greater patient adherence to recommended antibiotic
treatment, but it could also encourage riskier health behaviour and entail potentially adverse equity implications
for patients across generations and socioeconomic strata. Our empirical ﬁndings inform the clinical literature on
increasingly propagated point-of-care biomarker tests to guide antibiotic prescriptions, and we contribute to the
anthropological and sociological literature through a novel conceptualisation of the patient-health system in-
terface as an activity space into which biomarker testing is introduced.
1. Introduction
Antibiotics procured through formal and informal channels are
popularly over- and misused across high-, middle-, and low-income
countries, which contributes to the development of antimicrobial re-
sistance (AMR) and potentially to the spread of resistant bacteria across
the world (Butler et al., 2009; Kumarasamy et al., 2010; Morgan et al.,
2011). A range of antibiotic policies and interventions have emerged to
improve clinical antibiotic prescriptions worldwide (Davey et al.,
2017), including biomarker tests to inform healthcare workers’ (HCWs’)
prescription decisions (Nora et al., 2017). C-reactive protein (CRP) as a
biomarker of bacterial infection is one of these interventions (Lubell
et al., 2015), and new point-of-care testing (POCT) solutions are hoped
to become an additional tool for low- and middle-income countries
(LMICs) to limit the growing problem of AMR (Do et al., 2016; Drain
et al., 2014; Lubell and Althaus, 2017).
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In the context of AMR, host-response biomarkers such as CRP aim at
identifying patients requiring an antibiotic while helping to rule out
antibiotic prescriptions when an illness is caused by a mild bacterial
infection or by a viral infection (for which antibiotic treatment would
be ineﬀectual) (Aabenhus et al., 2014, 6). As a diagnostic tool, CRP
POCT can therefore indicate whether an antibiotic might be needed, but
it does not provide information about which speciﬁc antibiotic would
be best suited for treating the patient (Lubell et al., 2015). A review by
Aabenhus et al. (2014, 6) also lists a range of potential disadvantages of
such point-of-care tests, including “suboptimal use of time, costs,
handling errors, patient dissatisfaction and false negative values that
can lead to lack of necessary antibiotic treatments or false positive
values that may increase inappropriate antibiotic use.” The rationale
behind their introduction is therefore not that they are perfect diag-
nostic devices, but that they can aid and support clinical diagnosis in a
resource-poor environment of high or ill-targeted antibiotic use until
superior and aﬀordable pathogen-speciﬁc tests become available
(Lubell and Althaus, 2017).
While the recent sociological and anthropological literature on
rapid diagnostic testing for malaria has expanded our understanding of
POCT technologies in LMIC health systems, very little experience exists
with non-malaria POCT. This study examines the case of Chiang Rai in
northern Thailand, where we collected qualitative data from 58 fever
patients and healthcare workers alongside a clinical trial of CRP POCT
to reduce antibiotic prescriptions. Our exploratory research question is,
“What role does CRP POCT play in primary-care-level antibiotic prescription
within an existing system of practices at the patient-health system inter-
face?”, for which we draw on a novel analytical framework that bor-
rows arguments from the treatment-seeking behaviour, street-level
bureaucracy, and actor-network theory literature. We respond thereby
to recent calls from both social scientists (e.g. Chandler et al., 2016) and
medical researchers (e.g. Zellweger et al., 2017) for a greater involve-
ment of the social sciences in antimicrobial resistance research.
Our analysis will demonstrate that CRP POCT is introduced into a
context of existing antibiotic-related practices. The test becomes re-
deﬁned in relation to these practices, but it also alters them. Patients’
views are thus inﬂuenced by an understanding of CRP POCT as a
comprehensive blood test that provides speciﬁc diagnoses and that
corresponds to notions of good care. Healthcare workers use the test to
support their negotiations with patients but also to legitimise ethical
decisions in an increasingly restrictive antibiotic policy environment.
Commonly found positive attitudes, reassurance, and trust may there-
fore support the tests’ primary objective to reduce unnecessary anti-
biotic prescriptions, but they can also mask the unintended social
consequences of altering the patient-health system relationship.
2. Literature and framework
2.1. Related literature
The clinical literature has been considering the role of biomarkers
such as CRP or procalcitonin to inform and guide antibiotic prescrip-
tions in hospitals and primary care settings in high- as well as low- and
middle-income contexts (Hildenwall et al., 2017; Lubell et al., 2015;
Nora et al., 2017). This has led to the development of interventions
using biomarker point-of-care tests like CRP to target and reduce an-
tibiotic prescriptions for unspeciﬁed fevers and acute respiratory in-
fections (Aabenhus and Jensen, 2016; Aabenhus et al., 2014; Davey
et al., 2017). The growing number of clinical trials primarily from high-
income contexts thereby indicates moderate eﬀectiveness of CRP
testing in reducing clinically unnecessary antibiotic prescriptions
(Aabenhus et al., 2014; Cals et al., 2010; Cooke et al., 2015; Do et al.,
2016), making these point-of-care tests a promising and economical
addition to a necessarily broad portfolio of strategies to address anti-
microbial resistance in LMIC settings with resource constraints and
scarce laboratory capacity (Aabenhus and Jensen, 2016; Drain et al.,
2014; Lubell and Althaus, 2017). A small number of clinically oriented
qualitative and mixed-method studies from high-income countries
complement the clinical trials, focusing on CRP POCT adoption barriers
and the attitudes and practices of participating healthcare workers
(Bustinduy et al., 2017; Hardy et al., 2017; Huddy et al., 2016; Van den
Bruel et al., 2016).
Despite the growing interest in the subject, we are not aware of
social research studies on point-of-care biomarker testing to guide an-
tibiotic prescriptions in LMICs. A related body of literature has explored
this subject in greater depth, namely anthropological and sociological
research on rapid diagnostic testing (RDT) for malaria in low- and
middle-income Africa and Asia. Studies in this area pay closer attention
to the social processes underlying the introduction of a new test into an
established system of healthcare practices, which can lead to unfore-
seen implementation challenges and consequences of seemingly simple
testing technologies (Beisel et al., 2016, 2; Chandler et al., 2011, 13).
Themes that have been addressed in this body of work include, for
example, healthcare providers’ adherence to test results (Burchett et al.,
2017; Umlauf, 2017); the implementation of diagnostic tests in private
pharmacies and antimalarial-selling stores (Hutchinson et al., 2015,
2017; Visser et al., 2017); the social processes and values associated
with the process of testing (Chandler et al., 2012; Hutchinson et al.,
2015, 2017); or the potentially adverse eﬀect of increasing antibiotic
prescription to compensate for lower antimalarial treatment (Hopkins
et al., 2017). These studies share an appreciation that RDTs’ introduc-
tion, integration, and possible interference with existing social settings
can yield unintended consequences for clinical practice, healthcare-
seeking behaviour, and the conceptualisation of the test itself. Based on
this literature, we could expect similar dynamics in CRP POCT in LMIC
settings. However, no research has yet explored whether non-malarial
point-of-care biomarker testing in the context of AMR is subject to si-
milar processes. The research gap could be attributed to the lack of
analytical guidance of how the introduction of a test at the patient-
health system interface could be conceptualised. We respond to this
conceptual challenge through our activity space framework.
2.2. Analytical framework
Our study considers the introduction of CRP POCT at the patient-
health system interface. We deﬁne this interface as a healthcare “ac-
tivity space;” that is, a social space in which patients navigate a
healthcare landscape that contains numerous and diverse health system
actors, not all of which patients will know or prefer. The introduction of
a point-of-care biomarker test may change the behaviours of both pa-
tients and healthcare providers, but it may also fail to do so in light of
existing healthcare-seeking patterns and healthcare solutions like
pharmaceutical use or other diagnostic tests. We chose the activity
space framing of our analysis to study the interaction of the test with (a)
the healthcare workers who use it, (b) the patients whose routine care is
aﬀected by the test, and (c) the existing patient-health system linkages
that might resonate or interfere with CRP POCT.
An activity space is not a theory but an analytical domain. In order
to structure and guide our analysis, we borrow speciﬁc elements from
diﬀerent bodies of social theory, namely from treatment-seeking be-
haviour to explore patient behaviour in pluralistic health systems, from
street-level bureaucracy to analyse the behaviour of frontline health-
care workers who face pressure from policies and guidelines as well as
from their patients, and from actor-network theory to consider the role
of CRP POCT in an existing network of behaviours and practices that
can shape not only the impact but also the meaning of the test (sum-
marised in Fig. 1 and described below). Drawing on these diﬀerent
bodies of literature does not mean that we aim at harmonising them.
Rather, we follow a constructive approach that borrows from these
theoretical strands and situates the CRP POCT in its social environment
to understand its meaning as well as its possible (social) implications.
We adopt elements from the following three bodies of literature to
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structure our analysis:
1 Treatment-seeking behaviour: This literature emphasises, among
others, the role of local sense-making processes, the multiplicity of
existing healthcare solutions, and the emergence of complex and/or
unforeseen healthcare pathways when a person becomes ill (Beals,
1976, 184–185; Colson, 1971, 234–236; Kroeger, 1983, 149; Lieber
et al., 2006, 469). When studying the introduction of a biomarker
test, we are interested in people’s existing patterns of behaviour. In a
ﬁrst step to understanding the role of CRP POCT, our analysis will
therefore explore patients’ behaviour during illness, and the role of
antibiotics as part of this behaviour.
2 Street-level bureaucracy: This body of work highlights the pres-
sure that healthcare workers face from “below” (patient demands)
and “above” (policies, guidelines, and superiors) when executing
their work (Lipsky, 2010). It also emphasises the freedom of front-
line actors vis-à-vis these pressures, leaving them to seize “room for
manoeuvre” in accordance with their job description, professional
guidelines, and their personal constraints and objectives (Mosse,
2004; Sheikh and Porter, 2010). A central premise for our analysis is
that healthcare workers will already employ a range of tactics to
manage patient and policy demands in the context of antibiotic use,
not all of which will necessarily appear as “desirable” from a public
health perspective. We will analyse these practices in order to un-
derstand the range of prescription behaviours and tactics that CRP
POCT potentially inﬂuences.
3 Actor-network theory: Within the actor-network theory literature,
not merely humans but also objects can be understood to have
agency—that is, to inﬂuence relationships and prompt action in-
stead of being merely subject to instrumental usage (Coupaye, 2009;
Latour, 2005). We will assume that through interactions and over-
laps with other healthcare practices and solutions, CRP POCT may
not only compete with other options, but that it can take on new and
potentially unforeseen social roles. While our analysis in this paper
does not foreground CRP POCT in the same manner as an actor-
network analysis would, we will start from the accepted premise
that new interventions like biomarker tests are not introduced into a
vacuum, but into a system of healthcare solutions with which the
test potentially interacts and competes (Polgar, 1963, 411–412).
Our analysis will then explore the various roles that CRP POCT
fulﬁls in light of patients’ healthcare-seeking behaviour on the one
hand, and healthcare workers’ prescription behaviour on the other
hand.
In summary, in order to understand the social implications of CRP
testing in Northern Thailand, we locate patients, public healthcare
workers, and the intervention in an activity space framework that fo-
cuses on patients’ complex healthcare-seeking processes, healthcare
workers’ prescription strategies, and the CRP biomarker tests’ potential
inﬂuence in altering the existing relationships between patients and
healthcare workers. For our analysis, we will ﬁrst situate the antibiotic
policy and its use in the local historical and social context, after which
we will examine the perspectives of patients and healthcare workers
and then explore how the introduction of CRP POCT alters the given
assemblage of care. We expect that CRP biomarker testing can inﬂuence
healthcare workers’ and patients’ behaviours beyond the instrumental
provision of diagnostic information.
3. Materials and methods
3.1. Site description
This study is situated in Chiang Rai province in Northern Thailand.
According to the 2015 Household Socio-Economic Survey, the North is
Thailand’s poorest region with an average monthly household income
of THB 18,952 (approx. GBP 450) compared to the national average of
THB 26,915 (approx. GBP 650) (National Statistical Oﬃce, 2016).
Chiang Rai is a decentralised province where the bulk of economic
activity is generated in the northern border areas. Our ﬁeld site—the
capital city district Amphoe Mueang located in central Chiang Rai—-
comprises heterogeneous social groups ranging from Thai urban
dwellers to remotely located ethnic minority populations, who com-
monly work in agriculture or as daily labourers and who experience
physical and linguistic obstacles to accessing public healthcare (or ﬁnd
access to hospitals altogether impossible during the monsoon season).
In terms of its health system, Thailand has undergone rapid pro-
gress, indicated for example by an increase in female life expectancy by
9.8–78.6 years and a decrease in infant mortality from 35 to 6.4 deaths
per 1000 live births between 1990 and 2013 (WHO Regional Oﬃce for
South-East Asia, 2017, 9). A major development during this period was
the extension of universal healthcare in 2002, with an associated ex-
pansion of primary care facilities and a reduction in out-of-pocket
healthcare payments from 33% of total health expenditures in 2001 to
12% in 2014 (Jongudomsuk et al., 2015, 87; World Bank, 2017). The
current structure of the health system on the provincial level comprises
a provincial hospital (the Chiang Rai Prachanukroh Hospital), which
oversees the District Health Oﬃce (covering 50,000 people on average)
and the subordinate health centres, which cover on average 5000
people at the primary care level (Jongudomsuk et al., 2015, 23–24, 86).
Primary care providers like nurse practitioners can prescribe antibiotics
(Sumpradit et al., 2015, 47–48), and widespread village-level health
volunteers (assigned by public health centres) as well as private-sector
and informal providers accompany public healthcare provision
(Chuengsatiansup and Srivanichakorn, 2007, 5; Jongudomsuk et al.,
2015, 133).
3.2. Study design
This social study took place as part of a larger experimental trial on
the introduction of CRP POCT in primary care settings in peri-urban
and rural Chiang Rai district from June 2016 to August 2017
(ClinicalTrials.gov Identiﬁer: NCT02758821). The primary objective of
the trial was “to assess the impact of CRP [POCT] on healthcare
workers’ antibiotic prescribing in patients presenting to primary
healthcare centres with an acute fever or a recent history of fever,”
thereby measuring in particular whether antibiotic prescriptions were
safely reduced (“safely” e.g. in terms of symptom duration and severity
of symptoms) and/or better targeted towards bacterial infections.
Participating fever patients were recruited across six health centres and
randomised into one of two treatment groups (with diﬀerent CRP cut-
oﬀ levels for antibiotic prescription) and one control group, with 200
adults and 200 children enrolled per group (i.e. 1200 in total). The
patients were provided with brief information about the role of anti-
biotics and the risk of antibiotic resistance as part of the consent pro-
cess, and posters summarising the study were displayed in the waiting
Fig. 1. Conceptual framework for analysing role of CRP testing at health system – patient
interface.
Source: Authors.
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areas. The treatment groups were also presented with a 5-min animated
video presented by a Thai doctor, who explained antibiotics (using
technical terms and the word “germ killer” [see Section 5.1] alongside
antibiotic names and images), AMR (drawing on notions of bacteria and
viruses), and CRP POCT (showing laboratories, scientiﬁc graphs, and
bacteria and viruses) (The video is available at https://youtu.be/
hJnxSwbqWOE).
The treatment groups were tested for CRP at their ﬁrst visit.
Following the screening of fever patients, dedicated research study
nurses administered the 5-min CRP test. The process involved a ﬁnger
prick to draw a drop of blood (10 s), to which would be added a dilution
liquid (30 s), a conjugate (30 s), and a washing solution (20 s), after
which a NycoCard II® reader was used to analyse the solution, providing
a quantitative CRP result within 5min (the process is illustrated in Axis-
Shield PoC AS, 2016). Patients witnessed this process and received
explanations from the study staﬀ. The study staﬀ subsequently supplied
the CRP POCT results to the consulting healthcare worker to aid their
prescription decision, but healthcare workers were encouraged to base
the ultimate treatment decision on their own clinical judgement. The
control group had nasopharyngeal swabs and a venous blood sample
taken. All participants including control also had a physical examina-
tion, reported their medical history, and provided a urine sample on
enrolment. Follow-up visits for all participants involved CRP POCT
together with another urine sample and follow-up questions to help
gauge clinical recovery. Written consent was obtained from all parti-
cipants. The research was approved by the University of Oxford Tro-
pical Research Ethics Committee (ref. 49-15), Mahidol University Fa-
culty of Tropical Medicine Ethics Committee (ref. 16-015), and the
Chiang Rai Provincial Public Health Oﬃce Ethics Committee (ref. CR
0032.002/3516).
The experimental study design prevented us from adopting ob-
servational and/or ethnographic research methods, due to which we
relied on qualitative data from semi-structured interviews and focus
group discussions with fever patients and healthcare workers (the
purpose of the focus groups was to triangulate and to explore the
themes arising from the semi-structured interviews in greater depth).
The data were collected in August 2016 and May 2017, involving pre-
and post-intervention patients and healthcare workers. All 21 partici-
pating healthcare workers (including health centre principals) partook
in the interviews, seven of whom were interviewed prior to the inter-
vention. Patient sampling was purposive, geared towards maximum
variation. The variables that informed the sampling strategy were the
patients’ study groups (pre-intervention/control/treatment group),
whether they received an antibiotic (yes/no), gender (male/female),
age (guardian of a child below 18 years/18–49/50+), and education
(below/above primary education). We sampled the patients from logs
of fever patients maintained by the clinical trial and the health centres
(for pre-intervention patients), and ultimately recruited 27 fever pa-
tients for semi-structured interviews and 10 patients for three focus
group discussions (male/pre-intervention, female/post-intervention,
guardian/post-intervention). We chose maximum variation sampling
considering the exploratory nature of this research, for which we aimed
to capture the spectrum of behaviours and conceptions among primary
healthcare users, and their implications for the role of the CRP POCT.
By studying the perspectives of patients and healthcare workers within
and outside of the clinical trial setting, we were able to explore the role
of CRP POCT at the interface of these social agents more comprehen-
sively.
We based the interview guides (see Supplementary Material) on our
analytical framework. Healthcare worker interviews covered the
structure of everyday work, antibiotic prescription practices, and how
CRP POCT relates to these practices. Patient interviews addressed
treatment-seeking behaviour, the landscape of healthcare providers,
and healthcare experiences including CRP testing. A drug card devel-
oped with the help of study staﬀ and a local pharmacist facilitated the
patient interviews (see Supplementary Material). It was employed as a
tool to help recall medicines used during an illness and contained pic-
tures of common medicines in the form of pills and capsules (rather
than their packaging). While the drug card aided recall, it was less
useful for deciding ﬁrmly on the type of medicine used by the re-
spondent because many antibiotics looked alike (e.g. red-black capsules
for penicillin and cloxacillin) and non-antibiotic medicine like the tra-
ditional Thai herbal medicine fah talai jone also appeared in similar
capsules (this, however, enabled us to study for instance the theme of
look-alike non-antibiotic alternatives in greater depth).
All interviews were conducted in Thai, audio recorded, and tran-
scribed and translated together with hand-written ﬁeld notes. The
translation of the transcripts was meaning based (rather than literal
translation) and conducted by the research team member who carried
out the interviews (NC). The translation took place with daily con-
versations with the lead social researcher (MJH; both were present in
all interviews), which helped interpret diﬃcult concepts (e.g. related to
popular concepts of antibiotics, idioms). Annotations and notes in the
transcripts provided further information on the interview setting, the
interviewer-respondent interaction, and the interpretation of the re-
spondent’s statements. The resulting qualitative data comprised 51:39 h
of recorded material from 58 participants. We used thematic analysis
and our analytical framework formed the basis for the initial themes
that guided the qualitative analysis. Emerging and sub-themes were
then derived from the qualitative material. The lead researcher (MJH)
coded the data in Nvivo 11 (QSR International, 2017) using the trans-
lated transcripts, and all themes were discussed with and checked for
consistency and authenticity by the Thai research team member (NC).
The resulting themes were subsequently discussed in the broader re-
search group. We analysed the focus group discussions and semi-
structured interviews separately, but, due to their supplementary pur-
pose, the focus group discussions speak to and triangulate the themes
from the semi-structured interviews. We will therefore present excerpts
from semi-structured interviews and focus group discussions side-by-
side to exemplify the themes in the “Results” section (Section 5).
4. Case study context
4.1. Recent developments and current state of antibiotic policy and use
In this section, we will situate the current state of antibiotic policy
and use in Thailand in their historical and social context. Thailand has
been described as a context of high antibiotic consumption, indicated
for example by widespread over-the-counter antibiotic access
(Apisarnthanarak et al., 2008; Khamsarn et al., 2016, 272) and esti-
mated direct costs of drug-resistant infections of up to 1.6% of total
national health expenditure (Phumart et al., 2012, 358). Thai health
policy has been adapting to this problem at least since 1998 when AMR
surveillance was initiated, but only recently have eﬀorts become more
integrated (Tangcharoensathien et al., 2017). Among several recent
initiatives is the 2007 “Antibiotic Smart Use” campaign to promote the
“rational use of antibiotics” (Sumpradit et al., 2012, 905). It targets
antibiotic prescriptions and patient behaviour through activities in-
cluding treatment guideline training, addressing vernacular notions of
antibiotics as “anti-inﬂammatory medicine” (“ยาแกอักเสบ” or “yah kae
ak seb”), and promoting the prescription of herbal medicine for mild
and non-bacterial infections (andrographis paniculate, colloquially
known in Thailand as “ฟ าทะลายโจร” or “fah talai jone”) (ReAct, 2016, 5;
So and Woodhouse, 2014, 84; Sumpradit et al., 2012, 907). AMR is also
visible in the Thai National Strategic Plan on Antimicrobial Resistance,
which aims to reduce AMR-related morbidity by 50% and antibiotic
prescriptions by 20% by 2021 (MPH and MAC, 2017). According to
recent reports, current antibiotic prescription in Thailand is compara-
tively moderate with a mildly declining trend (WHO SEARO, 2016),
contrary to many of Thailand’s regional peers. For example, a review of
public-sector antibiotic prescriptions in the WHO Southeast Asia region
by Holloway et al. (2017, 11) suggests that Thailand has the lowest rate
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of prescriptions for outpatients (12% vs. unweighted regional average
of 39%) and the second-lowest rate of prescriptions for patients with
upper respiratory infections (43% vs. average of 61%).
In our research setting in Chiang Rai, elements of these antibiotic
policy developments had begun to diﬀuse into antibiotic prescription
practice on the primary care level. Guidelines have become increasingly
more restrictive, prescription monitoring from higher administrative
levels has intensiﬁed, and antibiotic prescription has been managed
more quantitatively. At the same time, local activities also emerged at
the health centre level, including posters, information leaﬂets about
antibiotic use, or monitoring of local stores to check whether they sell
prescription drugs over the counter. Local antibiotic prescription and
usage data from Chiang Rai is scarce. A survey of 25 villages in Chiang
Rai in the mid-1990s found that all of them had antibiotics locally
available, typically through informal channels and comprising various
brand names, types, and mixtures with other medicines (“ยาชุด” or “yah
shood,” meaning “medicine sets”) (Sringernyuang, 2000, 54, 58). An-
tibiotics in this survey accounted only for a small share of pharma-
ceutical treatment of illnesses (used in 3% of all recorded illnesses)
compared to analgesics and cough relievers, but the widespread avail-
ability suggests at least a general acquaintance with antibiotics among
the study population (Sringernyuang, 2000, 90). At the same time, the
emphasis on yah shood in this and other studies (e.g. Chuengsatiansup
et al., 2000, 19) is at odds with our observations, as we witnessed only
isolated second-hand reports of yah shood use during our one-year re-
search period in Chiang Rai (contrary e.g. to related research that we
carried out in Yangon; Khine Zaw et al., in press).
4.2. Historical roots and the social meaning of Thai antibiotic use
Historical context helps to understand the roots of widespread
medicine use (including antibiotics) and the implications of the current
AMR policies. Over the past century, approaches to health and medicine
in Thailand gradually evolved from an elite- and modernism-driven to a
more participatory and multi-disciplinary discourse from the 1970s
onwards (Muksong & Chuengsatiansup, forthcoming). During the
modernist paradigm (which overlapped for instance with the ﬁrst Five-
year National Health Development Plan in 1962; Sringernyuang, 2000,
29), health in Thailand became “wedged to [the] biomedical model of
health” and entailed the “medicalisation of health” (Muksong &
Chuengsatiansup, forthcoming, 10). The associated primacy of Western
pharmaceuticals in the Thai health system during the modernisation
discourse was followed by a primary healthcare approach and the
promotion of traditional Thai medicines in the 1980s, which are now
used and promoted as an alternative to pharmaceutical treatment in
general and antibiotic prescription in particular (Chuengsatiansup and
Srivanichakorn, 2007, 3–4; le Grand et al., 1993, 1025; So and
Woodhouse, 2014, 84; Tantipidoke, 2013, 4–5; WHO SEARO, 2016,
28–29). However, being a multidisciplinary and contested ﬁeld, a
plurality of actors has been driving health sector development in recent
years, involving not only community-based organisations but also for
example private for-proﬁt healthcare providers that had grown rapidly
as a means to ﬁll gaps in patchy rural health services (and public ﬁ-
nances); yet private providers also soon developed strong interest
groups and acquired a reputation for special if not superior medical
services like injections (Bennett and Tangcharoensathien, 1994;
Chuengsatiansup and Srivanichakorn, 2007, 7; Sringernyuang, 2000,
69). In addition, the pluralistic landscape of actors is uneven, as the
Thai health sector continues to be dominated by the biomedical logic of
medicine, which also penetrates the practice of traditional Thai medi-
cine with an increasing degree of medicalisation and commercialisation
(Tantipidoke, 2013, 4–5).
Because of these health sector developments, Western medicine has
oﬀered a widening portfolio of treatment even in rural contexts while
the popular knowledge about traditional Thai medicine has broken
down (Sringernyuang, 2000, 33; WHO SEARO, 2016, 28). During this
process, the sources of treatment and medicine have gradually become
more formalised, shifting—albeit incompletely—from traditional hea-
lers, local stores, and itinerant sellers to public and private clinics and
hospitals as well as registered pharmacies (le Grand et al., 1993, 1030;
Sringernyuang, 2000, 35). These developments are not entirely un-
problematic because informal stores and traditional healers do not only
fulﬁl functions of bridging healthcare gaps, but also provide alternative
systems of medicine and socially accessible healthcare when for in-
stance minority groups face discrimination or linguistic barriers in the
public healthcare sector (Apidechkul et al., 2016, 69; le Grand et al.,
1993, 1027; Tantipidoke, 2013).
As described above, widely accessible antibiotics even in rural set-
tings suggest that they are an integral part of Western medicine in
Thailand. At the same time, the uses of antibiotics do not seem to be
universal but concentrated around speciﬁc illnesses and symptoms. For
example, Sringernyuang (2000, 117–135) describes a case study of a
form of pelvic inﬂammatory disease that is popularly understood as
uterus inﬂammation (“มดลูกอักเสบ” or “mot look ak seb”). The author
hypothesises that pharmaceutical advertising had initially created a
conceptual link between this form of “inﬂammation” and speciﬁc an-
tibiotic brands, which later evolved into the generic use of antibiotics as
“anti-inﬂammatory drugs” through experimentation (e.g. because pa-
tients could not aﬀord the original brand). The establishment of this
conceptual link was facilitated by the mismatch between the biome-
dical logic of antibiotics and their popular notion as “anti-inﬂammatory
medicine” (considering the absence of notions of infection, bacteria,
and viruses in Thai traditional medicine), and people’s uncertainty re-
sulting from ambiguous deﬁnitions of the disease (Sringernyuang,
2000, 133–135). This in itself does not imply popular recognition as a
“wonder drug” as is occasionally claimed the clinical and social sciences
literature (e.g. Zellweger et al., 2017, 2969). Rather, antibiotics appear
to fulﬁl two purposes. On the one hand, the persistent link between
“inﬂammation” and antibiotics as “anti-inﬂammatory medicine”
(Khamsarn et al., 2016, 271) helps patients to establish a “popular
explanatory model” (i.e. mental framework) of illness and cure, thereby
reducing uncertainty in an ambiguous experience that merges biome-
dical and traditional notions of medicine (Sringernyuang, 2000,
133–135).
On the one hand, antibiotics satisfy generic expectations for med-
icinal treatment alongside other pharmaceuticals like analgesics (le
Grand et al., 1993, 1031). This expectation is rooted in the gradual
medicalisation and formalisation of healthcare in Thailand and corre-
sponds (a) to a “cultural context where people usually perceive that no
treatment is taking place unless drugs are prescribed” (Sringernyuang,
2000, 37), (b) to a higher perceived eﬀectiveness of Western and ex-
pensive as opposed to traditional Thai medicine, (c) to an environment
where 19 out of 20 illness episodes are being treated with medicine,
and (d) to the now widespread self-treatment with medicine especially
among poorer and socially marginalised parts of the Thai population
(Chuengsatiansup et al., 2000, 8–9, 28–29; Sringernyuang, 2000, 37,
80). The seemingly declining rate of antibiotic prescription thereby
masks high levels of general medicine use, indicated for example in a
reported average of 2.8 medicines prescribed per patient in public
primary care settings (WHO SEARO, 2016, 47). The policy attention on
reducing antibiotic prescription therefore raises questions about the
demand for other medicines like analgesics or non-steroidal anti-in-
ﬂammatory drugs, which have their own meaning and side-eﬀects,
which were commonly available in rural Chiang Rai at least until re-
cently, and which may not receive the same degree of global and local
policy attention as antimicrobials (Sringernyuang, 2000, 45–50).
In summary, CRP POCT is introduced into a context where—albeit
still worryingly high from a global health perspective—antibiotic use is
low compared to other countries in the region, following extensive
policy action and local initiatives. The historical pattern of antibiotic
use has to be considered alongside other Western pharmaceuticals,
which people have come to expect as the basis for medical treatment.
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The review thereby highlights that seemingly “individual or irrational
behaviour” around antibiotic use is structured by broad social and
historical processes in which pharmaceuticals have been heavily mar-
keted and citizens have been encouraged to think that care can only be
enacted if pharmaceuticals are provided (we thank an anonymous re-
viewer for these reﬂections). Among the many medicines that people
access for common ailments, antibiotics represent a comparatively
small part and may therefore not be considered the stereotypical
“wonder drug.” Yet, for speciﬁc symptoms and conditions, they have
integrated consistently into a local system of medicine and help reduce
uncertainty among patients. Potential reductions of antibiotic pre-
scriptions through CRP POCT could therefore relate to generic functions
of antibiotics as good care (alongside other medicine), and to speciﬁc
functions of reducing uncertainty for conditions that are conceptually
linked to antibiotic use.
5. Results
5.1. Patients’ healthcare-seeking behaviour
To understand the role of the CRP test at the patient-health system
interface, we ﬁrst document the conceptions and behaviours around
antibiotic use in Chiang Rai. We focus on the notions of “antibiotics”
encountered in the ﬁeld, and the various treatment-seeking patterns
that emanate partly from the local conceptions.
Varied local conceptions around the concept of antibiotics (sum-
marised in Table 1) emerged as a central theme in people’s treatment-
seeking behaviour. The Thai term for “antibiotic” was rarely uttered
among respondents and our interviewees rather referred to “anti-in-
ﬂammatory medicine,” “microbe [or germ] killer” and “sore throat
medication.” Members of diﬀerent ethnic groups like Akha or Lahu
reported that their language would not have an equivalent term for
“antibiotic” or the Thai “yah kae ak seb;” local equivalents of “anti-
biotic” would rather refer to medicine that “relieves the pain” – and use it
for muscle pain accordingly. Such was the case in an interview with an
Akha respondent (excerpt from interview notes):
Their language Akha does not have a word for “anti-inﬂammatory
drugs” (like Lahu). It refers to “getting rid of the pain.” They learned the
link between muscle pain and anti-inﬂammatory drugs [i.e. antibiotics]
through their experiences at the health centre. Their sole sources of health
information are the health centre and the hospital. (interview notes,
male guardian, no formal education, children in both treatment and
control groups)
Our interviews thereby consistently pointed at connections between
vernacular concepts of antibiotics (variously deﬁned) and their use for
speciﬁc symptoms, similar to their link to “มดลูกอักเสบ” (“mot look ak
seb”) in Sringernyuang (2000, 132–135) twenty years ago. In our case,
it appeared that antibiotics as “anti-inﬂammatory drugs” resonated
with people’s reported conceptions of sore throats (rather than fever)
and muscle pains as forms of bodily inﬂammation. Only few of the
interviewed patients would consider treating a simple fever with anti-
biotics and would rather depend on healthcare providers to prescribe
them. Rest, sponge baths, and paracetamol appeared to be the common
treatment for a fever instead. Furthermore, notions of antibiotics as
“sore throat medication” and “pain reliever” were uncommon but di-
rectly linked to the use for speciﬁc symptoms, which accompany fevers
only occasionally. (While our sample of fever patients in public primary
care settings does not allow a more comprehensive mapping of the link
between antibiotic conceptions and treatment-seeking patterns, we are
currently collecting survey data to test this relationship on the pro-
vincial level.)
Antibiotic access had further drivers beyond language. For example,
logistical access constraints (e.g. landslides during the rainy season)
would lead people in mountain villages to rely on local informal and
private healthcare providers when otherwise they would be drawn to
free healthcare services and medicine from public facilities. Another
important theme was that patients would ascribe diﬀerent values to
medicine received from various sources, with public and private
healthcare providers oﬀering better-quality medicine than local stores –
possibly stemming from the modernisation, formalisation, and medi-
calisation trends in the Thai health system over past decades. As a re-
sult, sets of mixed medicines called “ยาชุด” (“yah shood”) – though
widely known – appeared to be used rarely. Likewise, antibiotic access
through local stores and private pharmacies was primarily a resort for
patients who would require help outside of the opening hours of the
public health centres, who would emphasise their lack of time, or who
would value their own health beneath that of family members. An ex-
ample of the values associated with medicine from diﬀerent healthcare
providers is the following exchange with a male guardian, whose
daughter would receive antibiotics at a health centre, who would buy
antibiotics for himself at a pharmacy (requesting “anti-inﬂammatory”),
and who would buy antibiotics for his chickens from a local store:
R: “It’s one baht a pill [approx. GBP 0.02], normally the red and black
[presumably cloxacillin based on drug card] you can get them from
the shops for one baht a pill.”
Q: “Do you buy those? Do you buy the red and black to use?”
R: “I buy it for the chickens.”
Q: “But you don’t use it.”
R: “I don’t use chickens’ medicines.” (male guardian, primary
Table 1
Local expressions for “antibiotics” encountered in Chiang Rai.
Source: Authors, based on qualitative analysis.
English Thai Explanation
“Antibiotic” ยาปฏิชีวนะ
(“yah pa ti chee wa na”)
Technical term with Pali roots, rarely used (e.g. higher education levels); linked to varied
modes of use, e.g. sole dependence on doctors’ advice as well as self-medication for sore
throat
“Anti-inﬂammatory drug” ยาแก อักเสบ
(“yah kae ak seb”)
Common vernacular expression of antibiotics; sometimes referring to anti-inﬂammatory
drugs; often linked to sore throat, muscle pain, wounds, acne
“Microbe/germ killer” ยาฆ าเชื้อ
(“yah kah chuea”)
Vernacular description of antibiotics; may also include e.g. stomach medicine or rubbing
alcohol; linked to wide range of illnesses including fever in some instances
“Sore throat medication” ยาแก เจ็บคอ
(“yah kae jeb koh”)
Vernacular description linked to sore throat as commonly treated symptom; can also refer to
cough medicine/drops
“Amoxicillin” แอมม็อกซี่
(“amoxy”)
Vernacular expression of antibiotics as uttered literally, speciﬁc reference to antibiotics but
relatively uncommon (e.g. higher education, healthcare workers); uses similar to yah pa ti
chee wa na
“Medicine that relieves the
pain”
[no local language equivalent of Thai
“antibiotic” or “anti-inﬂammatory drug”]
Description of antibiotics without local language equivalent (e.g. Akha, Lahu); linked esp. to
use for muscle pain
Note. The order in which these concepts are presented does not imply a hierarchy of the terms, behaviours, or groups.
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education, treatment group)
His case illustrates the treatment-seeking patterns that result from
the ascribed value of medicine from diﬀerent healthcare providers.
More generally, guardians would maintain that their children’s health is
valuable and that they would not want to risk complications by buying
medicine from informal stores. In contrast, adults themselves argued
that they know their body, that they have more experience with illness
and medicine compared to their children, and that they can tolerate
stronger and/or lower-quality over-the-counter medicine. These dif-
ferences in ascribed eﬀectiveness of medicine from diﬀerent sources are
visible in statements such as,
“the health centre’s medicines work with my son, but not with the
grandparents,” (female guardian, secondary education, pre-inter-
vention group), and
“[I do not buy medicines for my children] because the kids have low
immunity and they cannot take strong medicines [from drug stores]. Us
adults can take medicines in [the form of] pills, right?” (female guar-
dian, primary education, intervention group),
And were conﬁrmed in the focus group discussion with guardians as
well:
“If it’s my child, I’d have to take her to the doctor. But if it’ me, I can just
buy the medication and take it” (focus group response of female
guardian, secondary education, treatment group).
Public healthcare providers were therefore often the preferred point
of treatment for the children. Adults would rather use medicine they
had stored at home or simply buy antibiotics at pharmacies and local
shops that are more “convenient” to access.
Like patients who seek medicine through private or informal
channels, those who actually visit public healthcare facilities would
commonly expect to receive medicine to make their visit worthwhile.
The resemblance to historically grown expectations of medicine as
“good care” is evident in statements like,
“I’m here [in the health centre] in hope to receive medicines, you
know?” (woman, primary education, treatment group), and
R: “Isn’t that right [to expect medicine]? When I go to a doctor … I
would expect from the doctor at the health centre to receive medicines to
relieve [my symptoms]. Because if I don’t receive anything, I would
have to ﬁnd other ways [to cure myself] because I’m sick, you know? I
would have to ﬁnd a way.”
Q: “Hm. Has it ever happened that you went and didn’t receive medicines
to take home?”
R: “It happened in the past, but … even when I went to the hospital. You
know what I got? Six paracetamols from [waiting] the whole day.”
(man, no formal education, treatment group)
These general expectations for pharmaceuticals in the case of fever
may neither be limited nor linked to antibiotics as “anti-inﬂammatory
medicine” or “sore throat medication” unless associated symptoms of
“inﬂammation” are present. The conversations rather suggested that
patients expecting an antibiotic could accept other treatment or advice
on how else to remedy the illness, provided that the substitute treat-
ment resonates with their generic expectations of good care.
In summary, treatment seeking in our sample of Chiang Rai fever
patients more commonly involved informal and private providers for
people who faced access constraints to public healthcare facilities and
for adults in general. The type of illness thereby inﬂuenced the
healthcare provider choice not so much directly, but indirectly through
considerations of what types of medicine would be suitable to treat the
illness, and where they could be obtained at an acceptable level of
quality. The conceptual links between antibiotics and treatment were
varied, and only some included the antibiotic treatment of fever. At the
same time, antibiotics also appeared to fall under the more general
category of pharmaceuticals that represent “good care.”
5.2. Healthcare workers’ prescription behaviour
When prescribing antibiotics (commonly reported e.g. for sore
throats, pneumonia, infected wounds, tonsillitis, diarrhoea, or urinary
tract infections), nurses negotiate constraints from “above” (policy and
administration) and from “below” (patients). From “above,” diagnosis
and prescription follow clinical practice guidelines, on which most in-
terviewed nurses were updated annually through conferences. These
conferences also introduced new policies and initiatives relating to
AMR, which was evident by occasional references to the “Antibiotic
Smart Use” campaign. Inﬂuences on prescription practice emerged also
from the provincial hospital, which had been managing and monitoring
the antibiotic supply to the health centres more closely. Healthcare
workers thereby suggested that more restrictive supply management
could help reduce antibiotic over-prescription because health centres
“wouldn’t have medicines to prescribe for the patients […], so that’s the end,
problem solved” (principal, pre-intervention site).
From “below,” healthcare workers occasionally faced unspoken
expectations or explicit demands for antibiotics. For example, an in-
tervention-site nurse described how she would normally adhere to
guidelines when a patient presents with sore throat, but antibiotic non-
prescription might also lead some patients to request antibiotics: “If I
don’t prescribe [an antibiotic] to these, I might get a dirty look. They know,
the villagers, ‘Oh do I not get the anti-inﬂammatory? Do I not get the germ
killer?’” (nurse, intervention site). Nurses reported that between one
patient per year to 50% of all their outpatients would articulate such
demands, but it was commonly raised as a theme that interfered with
nurses’ adherence to routine prescription guidelines (esp. if they lived
within the local community).
A portfolio of practices and tactics involving prescription and non-
prescription of antibiotics resulted from nurses’ negotiations of their job
description, clinical guidelines, the broader policy environment, and
patients’ explicit and implicit demands. These practices are summarised
in Fig. 2 together with example quotes. Most prescription decisions
were not deemed problematic, but when faced with patient demands,
nurses may prescribe antibiotics as they (a) surrender to continuously
insisting patients, (b) pity poor patients who incurred travel costs, (c)
consider it the lesser evil to provide supervised antibiotic prescriptions
than having the patient buy medicine from informal stores, or (d)
prescribe shorter courses to prevent patients from storing leftovers at
home. Nurses also reported tactics to dissuade patients from un-
necessary antibiotic use. While some “stood their ground” or tried to
convince patients through additional explanation, another common
tactic was to provide other medicine (e.g. paracetamol) or treatment
(e.g. massages) as alternatives to antibiotics. Nurses thereby also pro-
vided patients with the herbal medicine fah talai jone as a treatment for
sore throat (also because its capsules resemble antibiotics), and they
tapped into conceptual ambiguity to prescribe an “anti-inﬂammatory
drug” (e.g. nonsteroidal anti-inﬂammatory drugs) as literally requested
by patients expecting an antibiotic. Other practices involved having the
patient sign a statement that they understand the lacking necessity of an
antibiotic to deter them by reﬂection, or the deferral of the prescription
to (unlikely) follow-up visits if the patients’ symptoms would not im-
prove.
The principal insight from this analysis is that healthcare workers
decide actively about antibiotic prescriptions (rather than being passive
prescribers), and that they employ a range of solutions to limit over-
prescription. That healthcare workers do not constitute an “empty
vessel” for the biomarker test introduction might not be surprising in
itself, but the behaviours outlined in this section represent a set of
tactics and solutions that enable healthcare workers to make ethically
and socially laden prescription decisions under partial uncertainty. The
CRP POCT enters and interacts with these practices, as we will highlight
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below and discuss further in Section 6.
5.3. Roles of C-reactive protein point-of-care testing
The reception of the test was positive among the interviewed pa-
tients and healthcare workers. Nurses noted the additional information
that aided (though not replaced) the existing diagnostic process, and its
results are “better than only using words” (nurse, intervention site) when
trying to convince patients. Concerns arose only speculatively about the
workload and resource implications of a possible future scale-up of CRP
testing. Patients, too, responded positively to the CRP test. Aside from
passing worries about the pain of the ﬁnger prick and initial uncertainty
while they waited for the test results, the respondents expressed a liking
for the testing procedures they underwent, suggesting for example that
the treatment is “better with the blood test. They take care of you” (female
guardian, secondary education, treatment group). The overall opti-
mistic responses suggest that CRP POCT supports nurses and satisﬁes
patients, but the eﬀect on antibiotic prescription practices is more
nuanced for both parties.
On the side of the healthcare workers, the role of the test is manifest
for instance in its provision of additional information “that helps us
evaluate the patients faster” (nurse, intervention site), which can hide
nurses’ clinical uncertainty. One nurse (who was enthusiastic about the
clinical trial) explained that CRP POCT results might disagree with his
own judgement. Asked whether he trusts his own judgement in this
case, he likened CRP POCT to laboratory testing, suggesting that “I’ve
got to trust the lab result [laughed]. […] If the result says so, that means
there’s got to be something wrong somewhere in the body” (nurse, inter-
vention site). Conﬁdence in a CRP-aided prescription process can
therefore arise from conﬁrming an existing diagnosis but also from the
test’s ability to circumvent diagnostic uncertainty in guiding treatment.
Yet, the inﬂuence of CRP POCT was not pervasive, as other nurses relied
on their own judgement to override test results (as the clinical study
encouraged them to), and they continued referring uncertain and risky
cases to the hospital. If professional judgement and CRP POCT results
agreed that an antibiotic was not necessary for treatment, then the test
inﬂuenced the patient-nurse interaction by helping to “convince” the
patient of the credibility of the nurses’ recommendations: A nurse
considered that patients understand the test as “scientiﬁc evidence. It can
assure the patients explicitly. […] In some cases, I would say, ‘The lab result
Fig. 2. Tactics and justiﬁcations relating to antibiotic non-/prescription among Chiang Rai nurses, including example statements.
Source: Authors, based on qualitative analysis.
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looks like this. There’s no need [for an antibiotic].’” (nurse, intervention
site).
On the patient side, too, the test goes beyond being a mere diag-
nostic tool to detect bacterial infections. Contrary to its designed pur-
pose and despite an information video provided to participants during
the clinical trial, patients consistently re-interpreted the CRP ﬁnger
prick test as a comprehensive blood test, able to detect any disease in
the human body, or, for instance, “to know what’s wrong with my
daughter because they [i.e. the doctors] are afraid of her having a lethal
disease” (male guardian, primary education, treatment group). While
this indicates that the test is valued for its ability to rule out uncertainty
about the patients’ illness, the overall positive perception of (and re-
ported trust in) CRP POCT is potentially undermined by patients’ de-
mand for information about alternatives to antibiotic treatment, con-
tinued expectations to receive medicine that compensates for tedious
journeys to the health centre, and access to alternative treatment op-
tions if their symptoms do not improve despite CRP-POCT-guided ad-
vice (e.g., “If it doesn’t get better, I wouldn’t let them do the prick [again]; ”
woman, primary education, control group). This suggests that the care
experienced by the CRP POCT is only a partial substitute for the ex-
pectations of “good care” as pharmaceutical treatment.
In summary, CRP POCT does not only yield diagnostic information.
The test emerges as a new element in the assemblage of care, in which it
fulﬁls important social functions of “good care” and of reducing the
ambiguity that both patients and healthcare workers experience during
their encounter – similar though not identical to antibiotics. We will
discuss and interpret these ﬁndings in the social and historical context
of antibiotic use in the next section, together with their potential im-
plications for healthcare and antibiotic provision in Thailand.
6. Discussion
6.1. Situating CRP POCT within an existing network of solutions
This paper set out to study the role of CRP POCT on primary-care-
level antibiotic prescription in Chiang Rai. Our qualitative analysis
suggested that the introduction of the test into an existing system of
practices at the patient-health system interface leads to a redeﬁnition of
its role from a technical to a social device. In this section, we discuss the
ﬁndings from our analysis in light of the social and historical context
and the limitations of our study.
Antibiotic use in Chiang Rai corresponds historically to generic
expectations of Western medicine as “good care” while also relieving
ambiguity among patients and primary healthcare providers
(Sringernyuang, 2000, 133–135). Similarly, CRP POCT as a primary-
care-level intervention for fever patients helped alleviate therapeutic
ambiguity not only by reassuring patients about the nurses’ treatment
decisions, but also about their health. Drawing on Coupaye (2009,
444), we could argue that this reassurance arises from the values as-
sociated with overlapping tasks: CRP POCT resembles activities that
patients mainly associate with blood testing in hospital settings. Blood
and its transfer are imbued with meaning (Johnson et al., 2013), and
blood in our case has a particular importance as bearer of vital in-
formation about one’s health. Transferring blood to a medical expert
(i.e. a nurse) for scientiﬁc analysis through a technical device like the
CRP POCT bestows onto the test the diagnostic power of a compre-
hensive blood test. According to this explanation, patient reassurance
emanated from the values that had become associated with and em-
bedded into the POCT process, like care, reassurance, modernism, and
the value of scientiﬁc evidence. This reassurance led a wide range of
our respondents to trust that a low CRP level indicated good health (in
simple terms, a low CRP level indicates the absence of a bacterial in-
fection, even if a viral infection is present; and the level might also be
depressed by prior antibiotic use). We hypothesise that this response is
particularly pronounced if there is a mismatch between the internal
biomedical logic of the CRP POCT and patients’ own “explanatory
models” – which at least until recently did not commonly incorporate
notions of bacterial infection (Sringernyuang, 2000, 133–135).
We also presented evidence that patients perceive the CRP POCT
treatment as “good care.” At least in the context of this clinical trial,
participation meant additional care from study staﬀ who operated and
explained the test in addition to extensive trial-related procedures and
sample collection (e.g. urine tests), which was likely to accentuate the
impression of “good care” received by the patient. Further research will
have to explore the use of CRP POCT in routine care settings, and the
implications it has not only on antibiotic prescription but also on
healthcare-seeking patterns, social interactions between patients and
healthcare providers, and the use of alternative pharmaceutical and
non-pharmaceutical treatments. However, it is plausible that CRP POCT
ﬁlls a gap in a setting where antibiotic prescription as another route of
demonstrating and enacting care is being reduced more generally and
by the CRP POCT itself. CRP POCT thereby integrates into and partly
substitutes for pharmaceutical use.
At the same time, the range of patients’ healthcare-seeking patterns
in the pluralistic health system of Chiang Rai means that
(a) patients link the diverse notions of antibiotics to diﬀerent symp-
toms and conditions ranging from bacterial infections via in-
ﬂammation to sore throats and muscle pain (in line with their
functional descriptions), and that
(b) medicine access patterns often continue to involve (i) private
practitioners that are often seen as providing special medical ser-
vices compared public providers and (ii) pharmacies and local
stores if patients face logistical, economic, or social obstacles to
public healthcare access.
Healthcare-seeking behaviours could thus become incompatible
with fever-focused CRP testing at primary care units. Such incompat-
ibility would arise if (a) patients sought antibiotics for non-fever
symptoms like acne or muscle pain, and if (b) they did not normally
approach health centres for healthcare and medicine, but rather private
and informal providers like pharmacies or grocery stores. The social
role of the CRP POCT would then pertain only to (and replace social
functions of reduced antibiotic use for) a speciﬁc sub-population of
antibiotic users.
The role of the test was further deﬁned in relation to the policy
environment. CRP POCT was introduced into a setting where healthcare
workers noted the policy focus on antibiotic over-prescriptions and the
increasingly monitored supply of antibiotics from the Chiang Rai hos-
pital. As nurses’ routine practice has become infused with these con-
straints “from above,” the role of CRP testing expanded from diagnostic
support to allocative decision making that responds to an increasingly
restrictive policy environment. Some respondents did indeed suggest
that standardised indicators from CRP POCT could be a solution to
antibiotic over-prescription. This position is reminiscent of middle-
upper arm circumference bands, which according to Scott-Smith (2013,
923) introduced standardised indicators into the allocation process for
nutritional support within refugee camps (we adapted his quote to our
setting):
“[Measurement … allows] the [medical practitioner] to sort the
population eﬃciently into those who will and will not receive [an-
tibiotics], oﬀering a regularised mechanism for [prescription], and
transferring diﬃcult ethical decisions out of the [healthcare]
worker’s hands.” (Scott-Smith, 2013, 923)
As shown in Fig. 2 (which summarised the range of nurses’ anti-
biotic prescription tactics), the prescription process has an ethical di-
mension in which some nurses justiﬁed non-prescription with an ethical
responsibility to abide by their clinical guidelines, while other nurses
linked the prescription of antibiotics to their social responsibility to-
wards poorer patients living in remote locations. CRP POCT enters this
ethical space. As an allocative tool similar to middle-upper arm
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circumference bands, it can legitimise forms of antibiotic non-pre-
scription that were previously deemed in violation with the personal
ethics of the nurses. The introduction of the CRP POCT may further
reconﬁgure the social space between patients and healthcare providers
thus.
A central limitation of these interpretations is the restriction of our
study sample to (a) febrile patients who accessed public health centres,
and to (b) healthcare workers who participated (or agreed to partici-
pate) in the CRP biomarker test trial. We can therefore only capture
treatment-seeking patterns that took place outside the public sector
through circumstantial evidence of people’s experiences in previous
illness episodes. Our position as outsiders was a further complication,
potentially inﬂuencing responses through:
(a) power relationships indicated for example by education diﬀer-
entials (partial remedy: we introduced ourselves as students of the
respondents to learn from them)
(b) language and cultural distance (partial remedy: we interviewed in
northern Thai dialect and third-party translators)
(c) organisational constraints and insider-outsider power dynamics
with healthcare staﬀ.
It is possible that our themes thus omitted more critical and nega-
tive responses towards the health system and CRP POCT. Although our
broad range of participants yielded enthusiastic as well as critical re-
sponses, we cannot ascertain the extent to which the themes are re-
presentative for the broader population of patients and healthcare
workers. The clinical trial further inﬂuenced the perception of care by
the patient because CRP POCT was carried out under controlled con-
ditions by dedicated staﬀ and alongside other tests as part of the clinical
study. Methodologically, we were also limited by the absence of par-
ticipant observation methods to understand the direct encounter be-
tween patients and nurses and the role of the CRP POCT therein.
Although desirable, participant observation was unattainable within
the given clinical trial design into which this social research study was
embedded. Ethnographic ﬁeldwork would also have enabled a deeper
understanding of the CRP POCT from the perspective of actor-network
theory. The conclusions of this paper should therefore be read as one
among the ﬁrst steps towards understanding the social nature of point-
of-care biomarker testing and as hypotheses for further anthropological
and sociological enquiry to study biomarker tests in the context of AMR.
6.2. Potential consequences of CRP POCT
Based on our analysis, we consider the possible intended/unin-
tended and positive/negative operational consequences of biomarker
testing for primary-care-level antibiotic prescriptions in Chiang Rai
(summarised in Fig. 3). Considering our study limitations, these out-
comes are hypothetical and require further research to ascertain their
extent and impact.
The lead researchers of the CRP POCT trial expected that the test
would be complementary to antibiotic policy in Thailand, reducing
antibiotic prescriptions for febrile patients attending primary care, and
helping healthcare workers both as a diagnostic aide and as a com-
pliance tool for patients (whose trust in healthcare workers was ex-
pected to increase). The study team also expected that a CRP-POCT-
guided decision to not prescribe antibiotics might shift prescription
patterns within the participating health centres. In addition, healthcare
workers were expected to comply only partially with the test (based on
instructions to also rely on their own clinical judgement), and that
negative antibiotic prescription decisions might lead some patients to
explore alternative (private or informal) channels of antibiotic access.
While we report the quantitative results of the clinical trial on an-
tibiotics prescriptions elsewhere, our analysis suggests that CRP POCT
can realise its positive intentions and support diagnostic processes of
HCWs for low-risk “borderline” cases. Severe cases continue to be
referred to the hospital and seasoned nurses may tend to override dis-
agreeing test results (justiﬁably so if the test is considered a comple-
ment to clinical practice). The test results can further help reduce over-
prescription by building trust and convincing demanding patients.
However, improved antibiotic targeting can entail shifts in prescription
patterns to compensate for patients’ general demand for medicine, the
outcomes of which cannot be ascertained without further study.
Simultaneously, potentially persistent demand for antibiotics could
enable private and informal healthcare providers to absorb negative
CRP cases. The test may also have further unintended consequences.
For example, it might increase patient trust in public health care by
hiding rather than resolving HCW uncertainty, and by patients over-
estimating the diagnostic capabilities of the test. (We refrain here from
debating whether patients should understand the nature of the medical
procedures they undergo, focusing merely on the resulting behaviour.)
Positive compliance eﬀects may also be oﬀset by potentially risky
health behaviours emanating from false reassurances by a “compre-
hensive blood test” for patients with non-bacterial infections.
These outcomes are unlikely to be distributed evenly. In our study,
children appeared more likely to realise the intended positive con-
sequences because they tended to access public healthcare and their
guardians complied with nurses’ recommendations. Adults rather
sought help elsewhere, and, if they visited a health centre, often chal-
lenged the treatment decisions. With the clinical trial focus on fever,
CRP POCT may also miss patients who use antibiotics for conditions
like acne and muscle pain. Based on our analysis, we therefore hy-
pothesise a reduction in unnecessary antibiotic prescriptions, but also a
changing patient-health system relationship with adverse equity im-
plications across generations and socioeconomic strata.
6.3. Relation to the literature
On the surface, our ﬁndings correspond to the qualitative clinical
literature that highlighted positive patient and healthcare worker atti-
tudes associated with the introduction of CRP POCT in high-income
countries (e.g. Hardy et al., 2017; Huddy et al., 2016; Van den Bruel
et al., 2016). Our activity space approach helps to put these positive
attitudes into perspective. For example, the portfolio of nurses’ non-/
prescription tactics conﬁrms that CRP POCT is not introduced into an
“empty vessel” (Polgar, 1963, 411–412) and highlights the interactions
between the test introduction and the network of practices and its un-
derlying determinants (e.g. a demand to compensate costly and time-
consuming health facility visits rather than for antibiotics in particular;
Chandler et al., 2012, 1532; Umlauf, 2017, 8–9). These interactions
could entail unforeseen prescription patterns if antibiotics are not jus-
tiﬁed according to the CRP test but healthcare workers feel compelled
to satisfy a patient nonetheless. The evolving prescription patterns
following the introduction of point-of-care tests should be the subject of
further study.
Our patient interviews reﬂect further themes from the medical an-
thropology literature, for instance values associated with testing pro-
cedures. Patient reassurance arises from a conception that the analysis
of one’s blood yields treatment decisions based on full information. This
argument complements themes in Chandler et al. (2012, 1531–1532),
where RDTs also provided “psychological treatment” of patients, and it
relates to the importance of “testing blood” in Hutchinson et al. (2015,
56). In addition, considering the varied local conceptions of illness and
medicine, further research should explore how linguistic diﬀerences
between implementation contexts may aﬀect CRP POCT.
Lastly, through the activity space framework, we contribute to the
understanding of point-of-care tests as technologies that co-evolve with
their local context (Beisel et al., 2016, 2). This co-evolution is evident in
their re-interpretation as a comprehensive blood test and their role in
altering the behaviours and practices of patients and healthcare
workers. Our focus on the patient-health system interface oﬀers a novel
framework inspired by healthcare-seeking behaviour, street-level
M.J. Haenssgen et al. Social Science & Medicine 202 (2018) 1–12
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bureaucracy, and actor-network theory to study the role of these and
other health technologies in shaping healthcare practices and beha-
viours.
7. Conclusion
This paper studied the role of CRP POCT in Chiang Rai to reduce
unnecessary antibiotic prescriptions at the primary care level. We ap-
plied a multidisciplinary analytical framework that conceptualises the
patient-health system interface as an “activity space” populated with a
network of practices and solutions, within which CRP POCT is in-
troduced. This conceptualisation permitted us to draw on diﬀerent
theoretical threads to consider the behaviour of patients (treatment
seeking), healthcare workers (street-level bureaucracy), and the test
itself (actor-network theory). This work speaks to the empirical litera-
ture on CRP biomarker testing, and to the anthropological and socio-
logical literature on rapid diagnostic testing in LMICs.
Based on qualitative analysis of responses from 58 patients and
healthcare workers, we found that the test was reconﬁgured as a
comprehensive blood test for patients and as a negotiating tool that
provides a screen of certainty for healthcare workers. CRP POCT in-
teracted with and altered existing practices that link patients and the
health system, thus reinforcing healthcare worker conﬁdence, in-
creasing the social status of primary care facilities, and building patient
trust that potentially entails risky health behaviours. The test also
complements the increasingly restrictive antibiotic policy environment
in Chiang Rai. However, CRP POCT focusing on fever and respiratory
illnesses in public primary care settings may miss a wide spectrum of
other potentially unnecessary antibiotic prescriptions, and it may lack
eﬃcacy where no dependable alternative treatment or complementary
information is provided to patients.
The qualitative results are only indicative at this stage, but they
suggest that CRP POCT lives up to its aspirations of improving the
targeting of antibiotic prescriptions in Chiang Rai, although partly for
unintended reasons. We are still at an early stage of understanding
point-of-care testing and its impact on antibiotic prescriptions and
healthcare behaviour in LMICs. More research is needed to ascertain
eﬀects on prescription behaviour, distributional implications on dif-
ferent groups of patients, and how the policy environment and
healthcare practices, local perceptions of illness and medicine, and a
broader set of contextual and structural factors inﬂuence the nature,
eﬀectiveness, and usefulness of point-of-care testing.
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